IPHA News - Page 5 of 17 - IPHA

IPHA News

June 20, 2022

Give patients faster access to new medicines, writes Bernard Mallee

Irish patients deserve faster access to the best new medicines. We are slower than almost every other western European country to give the latest medicines to […]
June 19, 2022

Europe faces choice between innovation or the risk of stagnation, writes Bernard Mallee

A quarter of a century ago, almost half of global new treatments originated in Europe. Today, the proportion has dropped to 22%. The United States has […]
May 23, 2022

Ireland attracts fewer clinical trials than peer countries in Europe, says IPHA survey

More process efficiency urged as data shows Finland and Denmark outperform Ireland in drawing research activity Ireland is attracting fewer clinical trials than some European countries […]
May 11, 2022

Global Covid-19 vaccines equity of access is a ‘shared goal’ as production surges, says industry

Global equity of access to Covid-19 vaccines should be a shared goal, according to the research-based biopharmaceutical industry, with production set to reach 16.3 billion doses by […]
May 9, 2022

Ireland’s spending on medicines is ‘stable’ as patient access challenges persist, says IPHA

Ireland’s spend on medicines as a proportion of overall health expenditure is below the average of 15 other European countries, according an industry analysis of official […]
April 11, 2022

Ireland places 27th out of 35 countries for speed of access to new cancer medicines

Europe-wide survey of EMA-authorised medicines between 2017 and 2020 shows lengthening wait times for Irish patients  Germany is over four times faster than Ireland to make […]
March 21, 2022

Nine in 10 people believe vaccines are effective, according to Ipsos survey for IPHA

91% trust doctors and nurses for accurate information about vaccines Number of ‘vaccine believers’ up 11 points since before the pandemic Almost three in five adults […]
March 4, 2022

Biopharmaceutical industry responds to invasion of Ukraine

Following the invasion of Ukraine, the research-based biopharmaceutical industry is responding through solidarity, supply and support. We condemn the invasion of Ukraine and stands in solidarity […]
January 20, 2022

Better health and economic prospects depend on the right policy environment, writes Bernard Mallee

Recent figures showing buoyant tax revenues demonstrate the resilience of the economy during the pandemic. As some of the domestic sector struggles, the economy’s overall performance […]